Article Listing - Synthelabo Presents 1996 Highlights, New Research

FRENCH HEALTH SPENDING RISE

13 April 1992

French health care spending by the CNAM insurance fund rose 0.3% between December 1991 and January 1992. Spending in January...

US NEW PRESCRIPTI0N DRUG SALES IN 1991

13 April 1992

The leading new prescription pharmaceutical product in the USA last year was Wyeth-Ayerst's non-steroidal anti-inflammatory drug Lodine (etodolac), which received...

ROCHE CONSOLIDATED PROFIT LEAPS 56% IN 1991

13 April 1992

For 1991, Swiss pharmaceutical major Hoffmann-La Roche reported "continued and significant improvement in the group's earning performance," with consolidated group...

ORGANON LAUNCHES PHYSIOGINE IN FRANCE

13 April 1992

Organon has launched Physiogine (estriol), in 0.1% vaginal cream and 0.5mg capsule formulations for the local treatment of post-menopausal symptoms,...

HAFSLUND GOES FOR ITALIAN MARKET

13 April 1992

The Norwegian pharmaceutical and diagnostics company Hafslund Nycomed has started operations in Italy through its Milan-based subsidiary, and is about...

GYNEX TO MARKET DELATESTRYL

13 April 1992

Gynex Pharma has acquired US marketing rights to Bristol-Myers Squibb's Delatestryl (testosterone) as a treatment for male hypogonadism and delayed...

ROCHE'S MICROBIOLOGY DIAGNOSTIC BUSINESS SALE

13 April 1992

The Roche Diagnostics Systems Division of Hoffmann-La Roche and Roche Diagnostics Systems Inc have signed an agreement with Becton Dickin-son...

LEON JOINS RESEARCHLIFE

13 April 1992

Alberta Leon has joined Italian R&D company Researchlife following her resignation as chief executive officer at Fidia.

APPOINTMENTS AT WHITEHALL LABS

13 April 1992

Appointments at Whitehall Labs in the UK: Ray Edwards moves up to marketing director; Paul Hawkins is named as sales...

PASTEUR MERIEUX HIB VACCINE

13 April 1992

Pasteur Merieux has launched Hemophilus influenzae type B conjugate vaccine, called Act-HIB, onto the French market.

Showing 94311-94320 of 95341 articles